EQL Pharma is a pharmaceutical company. Currently, the focus is on development of niche and specialised pharmaceuticals, including everything from pharma for the treatment of diabetes, enlargement of blood vessels, as well as various infections and allergies. Primarily business is found in the Nordic market. EQL Pharma was founded in 2006 and is based in Lund.

Quotes for EQL Pharma AB

Right Now

+/-
-0.3
%
-0,81%
Latest
36.7
High
37
Low
36.6
Volume
7 831
Turnover (SEK)
287 483
Value (MSEK)
1 066,6

Board

CEO

  • Christer Fåhraeus

Chairman Of The Board

  • Anders Månsson

Board

  • Christer Fåhraeus
  • Lars Holmqvist
  • Linda Neckmar
  • Maria Bech
  • Rajiv I. Modi

Videos

Upcoming reports

  • 2021-08-18 Årsstämma 2021

  • 2021-08-18 Delårsrapport 2022-Q1

  • 2021-11-11 Delårsrapport 2022-Q2